| Trial ID: | L2604 |
| Source ID: | NCT02035644
|
| Associated Drug: |
Jinlida Granules
|
| Title: |
Study on the Efficacy aNd Safety of Jinlida Granules in Patients With Inadequately cOntrolled tYpe-2 Diabetes and dysLIpidemia Under liFe Style Intervention (ENJOY LIFE Study)
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes|Dyslipidemia
|
| Interventions: |
DRUG: Jinlida granules|DRUG: placebo granules
|
| Outcome Measures: |
Primary: change in HbA1c levels, 16 weeks | Secondary: fasting, postload 30-min and 2-h plasma glucose, 16 weeks|fasting, postload 30-min and 2-h serum insulin, 16 weeks|serum lipids, 16 weeks|glucose disposal rate (GDR) values from hyperinsulinemic euglycemic clamp, 16 weeks|incretins, 16 weeks|metabolomic parameters, 16 weeks|BMI, 16 weeks|blood pressures, 16 weeks
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Jiao Tong University School of Medicine | Collaborators: Shijiazhuang Yiling Pharmaceutical Co. Ltd
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
360
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-02
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2014-01-14
|
| Locations: |
Guang Ning, Shanghai, Shanghai, 200025, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02035644
|
